Izotropic Corporation (CSE:IZO)

Market Cap	17.62M
Revenue (ttm)	n/a
Net Income (ttm)	-2.75M
Shares Out	67.78M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	167,333
Average Volume	32,112
Open	0.2700
Previous Close	0.2600
Day's Range	0.2500 - 0.2700
52-Week Range	0.1900 - 0.4900
Beta	2.28
RSI	38.66
Earnings Date	Dec 30, 2025

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IZO